Vimarsana
Biggest News Aggregation in the World

Page 3 - Nasdaq Bdtx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bdtx Today - Breaking & Trending Today

Black Diamond Therapeutics (NASDAQ:BDTX) Raised to "Outperform" at Wedbush - Vimarsana News

Black Diamond Therapeutics (NASDAQ:BDTX) Raised to "Outperform" at Wedbush

Wedbush upgraded shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) from a neutral rating to an outperform rating in a research note published on Tuesday, Marketbeat Ratings reports. Wedbush currently has $10.00 price objective on the stock. Wedbush also issued estimates for Black Diamond Therapeutics’ FY2026 earnings at ($0.64) EPS and FY2027 earnings at […]

Stifel Nicolaus Upgrades Black Diamond Therapeutics (NASDAQ:BDTX) to "Buy" - Vimarsana News

Stifel Nicolaus Upgrades Black Diamond Therapeutics (NASDAQ:BDTX) to "Buy"

Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) was upgraded by analysts at Stifel Nicolaus from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, The Fly reports. The firm currently has a $10.00 price target on the stock, up from their previous price target of $2.00. Stifel Nicolaus’ price […]

Black Diamond Therapeutics (NASDAQ:BDTX) Raised to Buy at HC Wainwright - Vimarsana News

Black Diamond Therapeutics (NASDAQ:BDTX) Raised to Buy at HC Wainwright

HC Wainwright upgraded shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) from a neutral rating to a buy rating in a research note published on Wednesday, MarketBeat reports. They currently have $11.00 price objective on the stock. HC Wainwright also issued estimates for Black Diamond Therapeutics’ Q2 2023 earnings at ($0.61) EPS, Q3 2023 […]

Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded by Stifel Nicolaus to "Buy" - Vimarsana News

Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded by Stifel Nicolaus to "Buy"

Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) was upgraded by equities research analysts at Stifel Nicolaus from a “hold” rating to a “buy” rating in a report released on Thursday, The Fly reports. Several other research firms have also commented on BDTX. HC Wainwright upgraded shares of Black Diamond Therapeutics from a “neutral” rating to […]

Wedbush Comments on Black Diamond Therapeutics, Inc.'s Q2 2023 Earnings (NASDAQ:BDTX) - Vimarsana News

Wedbush Comments on Black Diamond Therapeutics, Inc.'s Q2 2023 Earnings (NASDAQ:BDTX)

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Rating) – Stock analysts at Wedbush raised their Q2 2023 EPS estimates for shares of Black Diamond Therapeutics in a research report issued on Tuesday, May 9th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($0.20) for the quarter, up from […]